References
Bancroft, J.; Tennent, G.; Loucas, K. and Cass, J.: The control of deviant sexual behaviour by drugs. 1. Behavioural changes following oestrogens and anti-androgens. British Journal of Psychiatry 125: 310–315 (1974).
Bathen, J.: Propranolol erectile dysfunction relieved. Annals of Internal Medicine 88: 716–717 (1978).
Bors, E. and Comarr, A.E.: in Neurological Urology, p.139 (University Park Press, Baltimore 1971).
Bulpitt, C.J. and Dollery, C.T.: Side effects of hypotensive agents evaluated by a self-administered questionnaire. British Medical Journal 3: 485–490 (1973).
Burger, H.G. and de Kretser, D.M.: Sexual impotence. Australian Prescriber 1: 115–117 (1977).
Carlson, H.E. and Ippoliti, A.F.: Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. Journal of Clinical Endocrinology and Metabolism 45: 367–370 (1977).
Conti, G.: L’erection du penis human et ses bases morphologivasculaires. Acta Anatomica (Basel) 14: 217–262 (1952).
Ebringer, A.; Doyle, A.E.; Dawborn, J.K.; Johnston, C.I. and Mashford, M.L.: The use of clonidine (Catapres) in the treatment of hypertension. Medical Journal of Australia 1: 524–526 (1970).
Fisher, C.; Schiavi, R.; Lear, H.; Edwards, A.; Davis, D.M. and Witikin, A.P.: The assessment of nocturnal REM erection in the differential diagnosis of sexual impotence. Journal of Sex and Marital Therapy 1: 277–289 (1975).
Franks, S.; Jacobs, H.S.; Martin, N. and Nabarro, J.D.N.: Hyperprolactinaemia and impotence. Clinical Endocrinology 8: 277–287 (1978).
Goble, A.J.: Sexuality and coronary heart disease. Patient Management 3 (No. 8): 25–31 (November 1974).
Greenblatt, D.J. and Koch-Weser, J.: Gynaecomastia and impotence: Complications of spironolactone therapy. Journal of the American Medical Association 223: 82 (1973).
Hallstrom, T. and Persson, T.: L-Dopa and non-emission of semen. Lancet 1: 1231–1232 (1970).
Khan, A.; Camel, G. and Perry, H.M.J.: Clonidine (Catapres): A new anti-hypertensive agent. Current Therapeutic Research 12: 10–18 (1970).
Kinsey, A.C.; Pomeroy, W.B. and Martin, C.E.: in Sexual Behaviour in the Human Male (Saunders, Philadelphia 1948).
Knarr, J.W.: Impotence from propranolol? Annals of Internal Medicine 85: 682–683 (1976).
Kolodny, R.C.; Masters, W.H.; Kolodner, R.M. and Toro, G.: Depression of plasma testosterone levels after chronic intensive marihuana use. New England Journal of Medicine 290: 872–874 (1974).
Kreuz, L.E.; Rose, R.M. and Jennings, J.R.: Suppressions of plasma testosterone levels and psychological stress: A longitudinal study of young men in officer candidate school. Archives of General Psychiatry 26: 479–492 (1972).
Kuhn, R.A.: Functional capacity of the isolated human spinal cord. Brain 73: 1–51 (1950).
Lawson, D.H.; Gloss, D. and Jick, H.: Adverse reactions to methyldopa with particular reference to hypotension. American Heart Journal 96: 572–579 (1978).
Lawson, D.M. and Gala, R.R.: The influence of adrenergic, dopaminergic, cholinergic and serotonergic drugs on plasma prolactin levels in ovariectomized, oestrogen-treated rats. Endocrinology 96: 313–318 (1975).
Legras, J.J.; Palem, M.; Servais, J. et al.: Basal pituitary-gonadal function in impotency evaluated by blood testosterone and LH assays; in Hormones and Brain Function, pp.527–529 (Plenum Press, New York 1973).
Lemere, F. and Smith, J.W.: Alcohol-induced sexual impotence. American Journal of Psychiatry 130: 212–213 (1973).
Miller, R.A.: Propranolol and impotence. Annals of Internal Medicine 85: 682–683 (1976).
Mintz, J.; O’Hare, K.; O’Brien, C.P. and Goldschmidt, J.: Sexual problems of heroin addicts. Archives of General Psychiatry 31: 700–703 (1974).
Newman, R.J. and Salerno, H.R.: Sexual dysfunction due to methyldopa. British Medical Journal 4: 106 (1974).
Peden, N.R.; Cargill, J.M.; Browning, M.C.K.; Saunders, J.H.B. and Wormsley, K.G.: Male sexual dysfunction during treatment with cimetidine. British Medical Journal 1: 659 (1979).
Pitts, N.E.: The clinical evaluation of prazosin hydrochloride, a new anti-hypertensive agent; in Cotton (Ed.) Prazosin: Evaluation of a New Antihypertensive Agent, pp.149–163 (Excerpta Medica, Amsterdam 1974).
Raboch, J.; Mellar, J. and Starka, L.: Plasma testosterone in male patients with sexual dysfunction. Archives of Sexual Behaviour 4: 541–545 (1975).
Rose, R.M.: Psychoendocrinology of the menstrual cycle. New England Journal of Medicine 299: 1186–1187 (1978).
Talbot, H.S.: The sexual function in paraplegia. Journal of Urology 73: 91–100 (1955).
von Graffenreid, B.; del Pozo, E.; Roubicek, J.; Krebs, E.; Poldinger, W.; Burmeister, P. and Kerp, L.: Effects of the synthetic enkephalin analogue FK 33-824 in man. Nature 272: 729–730(1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Horowitz, J.D., Goble, A.J. Drugs and Impaired Male Sexual Function. Drugs 18, 206–217 (1979). https://doi.org/10.2165/00003495-197918030-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197918030-00003